APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cosmetics Safety and Efficacy Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cosmetics Safety and Efficacy Testing Market Outlook and Growth Opportunities 2026

4 June 2026191 pages

Choose your research edition.

Industry ResearchCosmetics Safety and Efficacy Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cosmetics Safety and Efficacy Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cosmetics Safety and Efficacy Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cosmetics Safety and Efficacy Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cosmetics Safety and Efficacy Testing Market Analysis and Forecast 2026-2032181 pages · $4,950 USD

Market perspective

The global Cosmetics Safety and Efficacy Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cosmetics Safety and Efficacy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cosmetics Safety and Efficacy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cosmetics Safety and Efficacy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cosmetics Safety and Efficacy Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cosmetics Safety and Efficacy Testing market include SGS SA (Switzerland), Intertek Group Plc (United Kingdom), Eurofins Scientific SE (Luxembourg), Bureau Veritas SA (France), UL LLC (United States), Centre Testing International (China), PONY Testing Group Co., Ltd. (China), China Certification & Inspection Group (China) and Iwase Cosfa Co., Ltd. (Japan), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cosmetics Safety and Efficacy Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cosmetics Safety and Efficacy Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cosmetics Safety and Efficacy Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cosmetics Safety and Efficacy Testing market.

Cosmetics Safety and Efficacy Testing Segment by Company

SGS SA (Switzerland)

Intertek Group Plc (United Kingdom)

Eurofins Scientific SE (Luxembourg)

Bureau Veritas SA (France)

UL LLC (United States)

Centre Testing International (China)

PONY Testing Group Co., Ltd. (China)

China Certification & Inspection Group (China)

Iwase Cosfa Co., Ltd. (Japan)

Dermatest GmbH (Germany)

Microchem Laboratory (United States)

Kirei Testing Labo Co., Ltd. (Japan)

Cosmetics Safety and Efficacy Testing Segment by Type

Clinical Research Services

Cosmetics Testing to Regulation

Allergen Screening

Microbiology Testing

Ingredients Testing

Others

Cosmetics Safety and Efficacy Testing Segment by Application

Cosmetics

Oral Care Products

Sunscreen

Others

Cosmetics Safety and Efficacy Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cosmetics Safety and Efficacy Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cosmetics Safety and Efficacy Testing key companies, revenue, market share, and recent developments.

3. To split the Cosmetics Safety and Efficacy Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cosmetics Safety and Efficacy Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cosmetics Safety and Efficacy Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Cosmetics Safety and Efficacy Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cosmetics Safety and Efficacy Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cosmetics Safety and Efficacy Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cosmetics Safety and Efficacy Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cosmetics Safety and Efficacy Testing industry.

Chapter 3: Detailed analysis of Cosmetics Safety and Efficacy Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cosmetics Safety and Efficacy Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cosmetics Safety and Efficacy Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cosmetics Safety and Efficacy Testing Industry Trends Table 2. Cosmetics Safety and Efficacy Testing Industry Drivers Table 3. Cosmetics Safety and Efficacy Testing Industry Opportunities and Challenges Table 4. Cosmetics Safety and Efficacy Testing Industry Restraints Table 5. Global Cosmetics Safety and Efficacy Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cosmetics Safety and Efficacy Testing Revenue Share by Company (2021-2026) Table 7. Global Cosmetics Safety and Efficacy Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cosmetics Safety and Efficacy Testing Key Company Manufacturing Base & Headquarters Table 9. Global Cosmetics Safety and Efficacy Testing Company, Product Type & Application Table 10. Global Cosmetics Safety and Efficacy Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cosmetics Safety and Efficacy Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Clinical Research Services Table 15. Significant Companies of Cosmetics Testing to Regulation Table 16. Significant Companies of Allergen Screening Table 17. Significant Companies of Microbiology Testing Table 18. Significant Companies of Ingredients Testing Table 19. Significant Companies of Others Table 20. Global Cosmetics Safety and Efficacy Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Cosmetics Safety and Efficacy Testing Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Cosmetics Safety and Efficacy Testing Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Type (2021-2026) Table 24. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Cosmetics Table 26. Significant Companies of Oral Care Products Table 27. Significant Companies of Sunscreen Table 28. Significant Companies of Others Table 29. Global Cosmetics Safety and Efficacy Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cosmetics Safety and Efficacy Testing Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Cosmetics Safety and Efficacy Testing Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Application (2021-2026) Table 33. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Application (2027-2032) Table 34. Global Cosmetics Safety and Efficacy Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Cosmetics Safety and Efficacy Testing Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Region (2021-2026) Table 37. Global Cosmetics Safety and Efficacy Testing Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Region (2027-2032) Table 39. Global Cosmetics Safety and Efficacy Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Cosmetics Safety and Efficacy Testing Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Cosmetics Safety and Efficacy Testing Sales Value Market Share by Country (2021-2026) Table 42. Global Cosmetics Safety and Efficacy Testing Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Cosmetics Safety and Efficacy Testing Sales Value Market Share by Country (2027-2032) Table 44. SGS SA (Switzerland) Company Information Table 45. SGS SA (Switzerland) Business Overview Table 46. SGS SA (Switzerland) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. SGS SA (Switzerland) Cosmetics Safety and Efficacy Testing Product Portfolio Table 48. SGS SA (Switzerland) Recent Development Table 49. Intertek Group Plc (United Kingdom) Company Information Table 50. Intertek Group Plc (United Kingdom) Business Overview Table 51. Intertek Group Plc (United Kingdom) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Intertek Group Plc (United Kingdom) Cosmetics Safety and Efficacy Testing Product Portfolio Table 53. Intertek Group Plc (United Kingdom) Recent Development Table 54. Eurofins Scientific SE (Luxembourg) Company Information Table 55. Eurofins Scientific SE (Luxembourg) Business Overview Table 56. Eurofins Scientific SE (Luxembourg) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Eurofins Scientific SE (Luxembourg) Cosmetics Safety and Efficacy Testing Product Portfolio Table 58. Eurofins Scientific SE (Luxembourg) Recent Development Table 59. Bureau Veritas SA (France) Company Information Table 60. Bureau Veritas SA (France) Business Overview Table 61. Bureau Veritas SA (France) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Bureau Veritas SA (France) Cosmetics Safety and Efficacy Testing Product Portfolio Table 63. Bureau Veritas SA (France) Recent Development Table 64. UL LLC (United States) Company Information Table 65. UL LLC (United States) Business Overview Table 66. UL LLC (United States) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. UL LLC (United States) Cosmetics Safety and Efficacy Testing Product Portfolio Table 68. UL LLC (United States) Recent Development Table 69. Centre Testing International (China) Company Information Table 70. Centre Testing International (China) Business Overview Table 71. Centre Testing International (China) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Centre Testing International (China) Cosmetics Safety and Efficacy Testing Product Portfolio Table 73. Centre Testing International (China) Recent Development Table 74. PONY Testing Group Co., Ltd. (China) Company Information Table 75. PONY Testing Group Co., Ltd. (China) Business Overview Table 76. PONY Testing Group Co., Ltd. (China) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. PONY Testing Group Co., Ltd. (China) Cosmetics Safety and Efficacy Testing Product Portfolio Table 78. PONY Testing Group Co., Ltd. (China) Recent Development Table 79. China Certification & Inspection Group (China) Company Information Table 80. China Certification & Inspection Group (China) Business Overview Table 81. China Certification & Inspection Group (China) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. China Certification & Inspection Group (China) Cosmetics Safety and Efficacy Testing Product Portfolio Table 83. China Certification & Inspection Group (China) Recent Development Table 84. Iwase Cosfa Co., Ltd. (Japan) Company Information Table 85. Iwase Cosfa Co., Ltd. (Japan) Business Overview Table 86. Iwase Cosfa Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Iwase Cosfa Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Product Portfolio Table 88. Iwase Cosfa Co., Ltd. (Japan) Recent Development Table 89. Dermatest GmbH (Germany) Company Information Table 90. Dermatest GmbH (Germany) Business Overview Table 91. Dermatest GmbH (Germany) Cosmetics Safety and Efficacy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Dermatest GmbH (Germany) Cosmetics Safety and Efficacy Testing Product Portfolio Table 93. Dermatest GmbH (Germany) Recent Development Table 94. Microchem Laboratory (United States) Company Information Table 95. Microchem Laboratory (United States) Business Overview Table 96. Microchem Laboratory (United States) Cosmetics Safety and Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Microchem Laboratory (United States) Cosmetics Safety and Efficacy Testing Product Portfolio Table 98. Microchem Laboratory (United States) Recent Development Table 99. Kirei Testing Labo Co., Ltd. (Japan) Company Information Table 100. Kirei Testing Labo Co., Ltd. (Japan) Business Overview Table 101. Kirei Testing Labo Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Kirei Testing Labo Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Product Portfolio Table 103. Kirei Testing Labo Co., Ltd. (Japan) Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Cosmetics Safety and Efficacy Testing Product Image Figure 2. Global Cosmetics Safety and Efficacy Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cosmetics Safety and Efficacy Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Cosmetics Safety and Efficacy Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Clinical Research Services Image Figure 8. Cosmetics Testing to Regulation Image Figure 9. Allergen Screening Image Figure 10. Microbiology Testing Image Figure 11. Ingredients Testing Image Figure 12. Others Image Figure 13. Global Cosmetics Safety and Efficacy Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Cosmetics Safety and Efficacy Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Type (2021-2032) Figure 16. Cosmetics Image Figure 17. Oral Care Products Image Figure 18. Sunscreen Image Figure 19. Others Image Figure 20. Global Cosmetics Safety and Efficacy Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cosmetics Safety and Efficacy Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Application (2021-2032) Figure 23. Global Cosmetics Safety and Efficacy Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Cosmetics Safety and Efficacy Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Cosmetics Safety and Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 26. North America Cosmetics Safety and Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Cosmetics Safety and Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Cosmetics Safety and Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Cosmetics Safety and Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Cosmetics Safety and Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Cosmetics Safety and Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 32. South America Cosmetics Safety and Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Cosmetics Safety and Efficacy Testing Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Cosmetics Safety and Efficacy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Research Services
  • Cosmetics Testing to Regulation
  • Allergen Screening
  • Microbiology Testing
  • Ingredients Testing
  • Others
Applications
  • Cosmetics
  • Oral Care Products
  • Sunscreen
  • Others
Companies covered
  • SGS SA (Switzerland)
  • Intertek Group Plc (United Kingdom)
  • Eurofins Scientific SE (Luxembourg)
  • Bureau Veritas SA (France)
  • UL LLC (United States)
  • Centre Testing International (China)
  • PONY Testing Group Co., Ltd. (China)
  • China Certification & Inspection Group (China)
  • Iwase Cosfa Co., Ltd. (Japan)
  • Dermatest GmbH (Germany)
  • Microchem Laboratory (United States)
  • Kirei Testing Labo Co., Ltd. (Japan)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cosmetics Safety and Efficacy Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cosmetics Safety and Efficacy Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cosmetics Safety and Efficacy Testing Market Dynamics
  1. 2.1 Cosmetics Safety and Efficacy Testing Industry Trends
  2. 2.2 Cosmetics Safety and Efficacy Testing Industry Drivers
  3. 2.3 Cosmetics Safety and Efficacy Testing Industry Opportunities and Challenges
  4. 2.4 Cosmetics Safety and Efficacy Testing Industry Restraints
3 Cosmetics Safety and Efficacy Testing Market by Company
  1. 3.1 Global Cosmetics Safety and Efficacy Testing Company Revenue Ranking in 2025
  2. 3.2 Global Cosmetics Safety and Efficacy Testing Revenue by Company (2021-2026)
  3. 3.3 Global Cosmetics Safety and Efficacy Testing Company Ranking (2024-2026)
  4. 3.4 Global Cosmetics Safety and Efficacy Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Cosmetics Safety and Efficacy Testing Company Product Type and Application
  6. 3.6 Global Cosmetics Safety and Efficacy Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cosmetics Safety and Efficacy Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cosmetics Safety and Efficacy Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cosmetics Safety and Efficacy Testing Market by Type
  1. 4.1 Cosmetics Safety and Efficacy Testing Type Introduction
  2. 4.1.1 Clinical Research Services
  3. 4.1.2 Cosmetics Testing to Regulation
  4. 4.1.3 Allergen Screening
  5. 4.1.4 Microbiology Testing
  6. 4.1.5 Ingredients Testing
  7. 4.1.6 Others
  8. 4.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Type
  9. 4.2.1 Global Cosmetics Safety and Efficacy Testing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Type (2021-2032)
  11. 4.2.3 Global Cosmetics Safety and Efficacy Testing Sales Value Share by Type (2021-2032)
5 Cosmetics Safety and Efficacy Testing Market by Application
  1. 5.1 Cosmetics Safety and Efficacy Testing Application Introduction
  2. 5.1.1 Cosmetics
  3. 5.1.2 Oral Care Products
  4. 5.1.3 Sunscreen
  5. 5.1.4 Others
  6. 5.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Application
  7. 5.2.1 Global Cosmetics Safety and Efficacy Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Cosmetics Safety and Efficacy Testing Sales Value Share by Application (2021-2032)
6 Cosmetics Safety and Efficacy Testing Regional Value Analysis
  1. 6.1 Global Cosmetics Safety and Efficacy Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cosmetics Safety and Efficacy Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cosmetics Safety and Efficacy Testing Sales Value (2021-2032)
  7. 6.3.2 North America Cosmetics Safety and Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cosmetics Safety and Efficacy Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Cosmetics Safety and Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cosmetics Safety and Efficacy Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cosmetics Safety and Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cosmetics Safety and Efficacy Testing Sales Value (2021-2032)
  16. 6.6.2 South America Cosmetics Safety and Efficacy Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cosmetics Safety and Efficacy Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cosmetics Safety and Efficacy Testing Sales Value Share by Country, 2025 VS 2032
7 Cosmetics Safety and Efficacy Testing Country-level Value Analysis
  1. 7.1 Global Cosmetics Safety and Efficacy Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cosmetics Safety and Efficacy Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cosmetics Safety and Efficacy Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cosmetics Safety and Efficacy Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cosmetics Safety and Efficacy Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cosmetics Safety and Efficacy Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SGS SA (Switzerland)
  2. 8.1.1 SGS SA (Switzerland) Company Information
  3. 8.1.2 SGS SA (Switzerland) Business Overview
  4. 8.1.3 SGS SA (Switzerland) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SGS SA (Switzerland) Cosmetics Safety and Efficacy Testing Product Portfolio
  6. 8.1.5 SGS SA (Switzerland) Recent Developments
  7. 8.2 Intertek Group Plc (United Kingdom)
  8. 8.2.1 Intertek Group Plc (United Kingdom) Company Information
  9. 8.2.2 Intertek Group Plc (United Kingdom) Business Overview
  10. 8.2.3 Intertek Group Plc (United Kingdom) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Intertek Group Plc (United Kingdom) Cosmetics Safety and Efficacy Testing Product Portfolio
  12. 8.2.5 Intertek Group Plc (United Kingdom) Recent Developments
  13. 8.3 Eurofins Scientific SE (Luxembourg)
  14. 8.3.1 Eurofins Scientific SE (Luxembourg) Company Information
  15. 8.3.2 Eurofins Scientific SE (Luxembourg) Business Overview
  16. 8.3.3 Eurofins Scientific SE (Luxembourg) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Scientific SE (Luxembourg) Cosmetics Safety and Efficacy Testing Product Portfolio
  18. 8.3.5 Eurofins Scientific SE (Luxembourg) Recent Developments
  19. 8.4 Bureau Veritas SA (France)
  20. 8.4.1 Bureau Veritas SA (France) Company Information
  21. 8.4.2 Bureau Veritas SA (France) Business Overview
  22. 8.4.3 Bureau Veritas SA (France) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bureau Veritas SA (France) Cosmetics Safety and Efficacy Testing Product Portfolio
  24. 8.4.5 Bureau Veritas SA (France) Recent Developments
  25. 8.5 UL LLC (United States)
  26. 8.5.1 UL LLC (United States) Company Information
  27. 8.5.2 UL LLC (United States) Business Overview
  28. 8.5.3 UL LLC (United States) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 UL LLC (United States) Cosmetics Safety and Efficacy Testing Product Portfolio
  30. 8.5.5 UL LLC (United States) Recent Developments
  31. 8.6 Centre Testing International (China)
  32. 8.6.1 Centre Testing International (China) Company Information
  33. 8.6.2 Centre Testing International (China) Business Overview
  34. 8.6.3 Centre Testing International (China) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Centre Testing International (China) Cosmetics Safety and Efficacy Testing Product Portfolio
  36. 8.6.5 Centre Testing International (China) Recent Developments
  37. 8.7 PONY Testing Group Co., Ltd. (China)
  38. 8.7.1 PONY Testing Group Co., Ltd. (China) Company Information
  39. 8.7.2 PONY Testing Group Co., Ltd. (China) Business Overview
  40. 8.7.3 PONY Testing Group Co., Ltd. (China) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PONY Testing Group Co., Ltd. (China) Cosmetics Safety and Efficacy Testing Product Portfolio
  42. 8.7.5 PONY Testing Group Co., Ltd. (China) Recent Developments
  43. 8.8 China Certification & Inspection Group (China)
  44. 8.8.1 China Certification & Inspection Group (China) Company Information
  45. 8.8.2 China Certification & Inspection Group (China) Business Overview
  46. 8.8.3 China Certification & Inspection Group (China) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 China Certification & Inspection Group (China) Cosmetics Safety and Efficacy Testing Product Portfolio
  48. 8.8.5 China Certification & Inspection Group (China) Recent Developments
  49. 8.9 Iwase Cosfa Co., Ltd. (Japan)
  50. 8.9.1 Iwase Cosfa Co., Ltd. (Japan) Company Information
  51. 8.9.2 Iwase Cosfa Co., Ltd. (Japan) Business Overview
  52. 8.9.3 Iwase Cosfa Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Iwase Cosfa Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Product Portfolio
  54. 8.9.5 Iwase Cosfa Co., Ltd. (Japan) Recent Developments
  55. 8.10 Dermatest GmbH (Germany)
  56. 8.10.1 Dermatest GmbH (Germany) Company Information
  57. 8.10.2 Dermatest GmbH (Germany) Business Overview
  58. 8.10.3 Dermatest GmbH (Germany) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dermatest GmbH (Germany) Cosmetics Safety and Efficacy Testing Product Portfolio
  60. 8.10.5 Dermatest GmbH (Germany) Recent Developments
  61. 8.11 Microchem Laboratory (United States)
  62. 8.11.1 Microchem Laboratory (United States) Company Information
  63. 8.11.2 Microchem Laboratory (United States) Business Overview
  64. 8.11.3 Microchem Laboratory (United States) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Microchem Laboratory (United States) Cosmetics Safety and Efficacy Testing Product Portfolio
  66. 8.11.5 Microchem Laboratory (United States) Recent Developments
  67. 8.12 Kirei Testing Labo Co., Ltd. (Japan)
  68. 8.12.1 Kirei Testing Labo Co., Ltd. (Japan) Company Information
  69. 8.12.2 Kirei Testing Labo Co., Ltd. (Japan) Business Overview
  70. 8.12.3 Kirei Testing Labo Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kirei Testing Labo Co., Ltd. (Japan) Cosmetics Safety and Efficacy Testing Product Portfolio
  72. 8.12.5 Kirei Testing Labo Co., Ltd. (Japan) Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst